Perfromance Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-407	Closed	-$258K	–	198
2025 Q1	$258K	Buy	+407	New	+$258K	0.01%	144
2024 Q4	–	Sell	-207	Closed	-$218K	–	201
2024 Q3	$218K	Buy	207 +1	+0.5%	+$1.05K	0.01%	180
2024 Q2	$217K	Buy	+206	New	+$217K	0.01%	149